The effect on vision of associated treatments in patients taking vigabatrin: Carbamazepine versus valproate

被引:18
作者
Arndt, CF [1 ]
Salle, M
Derambure, PH
Defoort-Dhellemmes, S
Hache, JC
机构
[1] Hop Roger Salengro, Serv Explorat Fonct Vis, F-59037 Lille, France
[2] Hop Roger Salengro, Dept Physiol EA 2689, F-59037 Lille, France
[3] Hop Roger Salengro, Neurol Clin, F-59037 Lille, France
关键词
vigabatrin; visual field constriction; electrooculogram; electroretinogram; gamma-aminobutyric acid;
D O I
10.1046/j.1528-1157.2002.42001.x
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Purpose: To evaluate the effect on visual function of a concomitant antiepileptic drug (AED) in patients treated with vigabatrin (VGB). Methods: Sixty-four consecutive patients with a history of partial seizures currently treated with VGB with either carbamazepine (CBZ) or valproate (VPA) were examined with automated kinetic perimetry, static perimetry. electrooculogram (EOG), and electroretinogram (ERG). An original device based on kinetic perimetry was developed to quantify the area of perception for each isopter. Results: Fifty-two patients were finally included. The results showed a significant difference in patients treated with VGB-VPA compared with patients treated with VGB-CBZ concerning the mean defect of static perimetry and the peripheral and midperipheral isopter (III 4e and III 1a Goldmann equivalent, respectively) in kinetic perimetry. FOG and ERG results did not differ significantly between the two groups. Conclusions: The visual impairment due to visual field constriction was more important in patients treated with VGB and VPA compared with patients treated with VGB and CBZ. The origin of this difference between the two associations could not be related to any particular retinal electrophysiologic abnormality.
引用
收藏
页码:812 / 817
页数:6
相关论文
共 24 条
[1]   ROLE OF CHOROID-PLEXUS EPITHELIUM IN THE REMOVAL OF VALPROIC ACID FROM THE CENTRAL-NERVOUS-SYSTEM [J].
ADKISON, KDK ;
ARTRU, AA ;
POWERS, KM ;
NOCHLIN, D ;
SHEN, DD .
EPILEPSY RESEARCH, 1995, 20 (03) :185-192
[2]  
ADKISON KDK, 1994, J PHARMACOL EXP THER, V268, P797
[3]   Outer retinal dysfunction in patients treated with vigabatrin [J].
Arndt, CF ;
Derambure, P ;
Defoort-Dhellemmes, S ;
Hache, JC .
NEUROLOGY, 1999, 52 (06) :1201-1205
[4]  
ARTRU AA, 1994, J NEUROSURG ANESTH, V6, P193
[5]   Vigabatrin effect on inner retinal function [J].
Coupland, SG ;
Zackon, DH ;
Leonard, BC ;
Ross, TM .
OPHTHALMOLOGY, 2001, 108 (08) :1493-1496
[6]   Severe persistent visual field constriction associated with vigabatrin [J].
Eke, T ;
Talbot, JF ;
Lawden, MC .
BRITISH MEDICAL JOURNAL, 1997, 314 (7075) :180-181
[7]   MECHANISMS OF ANTICONVULSANT DRUG-ACTION .2. DRUGS PRIMARILY USED FOR ABSENCE EPILEPSY [J].
FAINGOLD, CL ;
BROWNING, RA .
EUROPEAN JOURNAL OF PEDIATRICS, 1987, 146 (01) :8-14
[8]   CHRONIC TOXICITY STUDIES WITH VIGABATRIN, A GABA-TRANSAMINASE INHIBITOR [J].
GIBSON, JP ;
YARRINGTON, JT ;
LOUDY, DE ;
GERBIG, CG ;
HURST, GH ;
NEWBERNE, JW .
TOXICOLOGIC PATHOLOGY, 1990, 18 (02) :225-238
[9]  
Harding GFA, 1999, DOC OPHTHALMOL, V97, P179
[10]   Separating the retinal electrophysiologic effects of vigabatrin - Treatment versus field loss [J].
Harding, GFA ;
Wild, JM ;
Robertson, KA ;
Rietbrock, S ;
Martinez, C .
NEUROLOGY, 2000, 55 (03) :347-352